| |
|||||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
| EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 11, Number 7, July 2005 New Lymphogranuloma Venereum Chlamydia trachomatis Variant, AmsterdamJoke Spaargaren,* Han S.A. Fennema,* Servaas A. Morré,† Henry J.C.
de Vries,‡ and Roel A. Coutinho§ |
||
|
|
![]() |
|
| Back to article | |
|
Figure. Schematic representation of the Chlamydia trachomatis ompA gene. In detail, variable segment 2 (VS-2): nucleotide and amino acid (aa) sequence comparison of the prototypes L1, L2, L2´, L2a, and L3 and the newly identified lymphogranuloma venereum (LVG) strain, which we designated L2b. Conserved nucleotides in VS-2 for all LGV strains are shown in red. The nucleotide substitutions in L2b as compared to all LGV strains is indicated by arrows. All aa encoded by the substitution combinations are indicated. CS = constant segment; omp = outer membrane protein. |
|
|
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
|
This page last reviewed June 15, 2005 |
|
|
Emerging
Infectious Diseases Journal |
|